• share
• favorite_border

In a new study, vision researchers found that certain types of lightbulbs and reading at different times of the day may contribute to nearsightedness, a condition clinically referred to as myopia. In another study, scientists found that a common food flavoring may offer new treatment options for reducing nearsightedness. The findings from the three new studies are being presented at the Association for Research in Vision and Ophthalmology (ARVO) in Honolulu, Hawaii, Sunday, April 29 – Thursday, May 3.

• share
• favorite_border

Three new studies demonstrate research findings that could offer novel treatments for vision and eye conditions. The studies will be presented at the 2018 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Honolulu, Hawaii, from Sunday, April 29 – Thursday, May 3.

• share
• favorite_border

Two new studies demonstrate potential future opportunities to use genetic information to treat vision conditions. The new studies are being presented at the 2018 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Honolulu, Hawaii, Sunday, April 29 – Thursday, May 3.

• share
• favorite_border

The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting is the largest gathering of eye and vision researchers in the world, with over 11,000 attendees from more than 75 countries. The five-day meeting will feature more than 6,000 poster and paper presentations of cutting-edge eye and vision research, offering an early glimpse into the latest advances in potential treatments for eye disease and blindness — often years ahead of their introduction to clinical practice.

• share
• favorite_border

The most recent basic and clinical research developments related to the diagnosis and treatment of eye cancer will be the focus of a scientific meeting convened by the Association for Research in Vision and Ophthalmology (ARV0) in partnership with the Champalimaud Foundation. The Ocular Oncogenesis and Oncology Conference will be held July 18 – 21 at the Champalimaud Centre for the Unknown, a state-of-the-art medical and research facility located in Lisbon, Portugal

• share
• favorite_border

Leading vision scientists from the U.S. and around the world will gather in Washington, DC on Feb. 9 to discuss federal research funding with members of Congress. The researchers will share examples of how investing taxpayer dollars into basic science has resulted in cost savings for patients and for the Medicare program overall.

• share
• favorite_border

A new study quantifying a 21-fold return on investment suggests an efficient — and non-partisan — method to cut healthcare spending is to invest in basic research. The paper tracks how a new technology aids doctors in reducing the number of unnecessary drug injections used to treat a blinding condition called wet age-related macular degeneration (AMD)

• share
• favorite_border

In a study well-timed for summer, vision scientists have found that eye freckles, dark spots on the colored part of the eye (iris), are more frequently found in people with higher lifetime exposure to sunlight. While not malignant, eye freckles could indicate the presence or risk of sunlight-triggered eye diseases like cataract or macular degeneration.

• share
• favorite_border

Three years after an Ebola epidemic swept across West Africa, researchers have found a clue to how the virus may live on in the eyes of survivors suffering from uveitis – one of the more serious and common complications of the disease.

• share
• favorite_border

A generic glaucoma drug has been shown to halt the progression of myopia (nearsightedness), potentially offering rapid approval for a new treatment of an incurable condition. The research is being presented at the 2017 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Baltimore, Md.

• share
• favorite_border

A new, personalized and noninvasive treatment using 3-D printed implants has been developed to help children born with abnormally small or missing eyes (microphthalmia/ anophthalmia, or MICA). The research is being presented at the 2017 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Baltimore, Md.

• share
• favorite_border

Scientists have developed a new method to clear antibiotic resistant bacteria from the surface of the eye – introducing a new strain of bacteria that preys on other microorganisms. The research is being presented at the 2017 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Baltimore, Md.

• share
• favorite_border

A survey of adult participants seen in an urban eye hospital revealed that one-in-five study participants had clinically significant depressive symptoms. The research is being presented at the 2017 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Baltimore, Md.

• share
• favorite_border

Scientists have demonstrated the capacity to grow specialized neurons that relay visual data to the brain, creating a source of cells for future treatments of glaucoma and other optic neurodegenerative diseases. The research is being presented during a press conference at the 2017 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Baltimore, Md., on Monday, May 8 from 9:30 – 10:15am.

• share
• favorite_border

Using augmented-reality (AR) display systems, scientists have restored visual function in the amblyopic (lazy) eyes of patients outside of the currently accepted window for treatment. The research is being presented at the 2017 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Baltimore, Md.

• share
• favorite_border

Surgeons have successfully used a remote controlled robotic system to operate inside the human eye, paving the way for future robotic assistance in clinical treatments that require extreme precision and stability, such as the controlled delivery of gene therapy and stem cells. The research is being presented at the 2017 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Baltimore, Md.

• share
• favorite_border

Scientists have demonstrated that a machine learning algorithm, using images of patients’ retinas obtained over time, can predict the critical moment when early or intermediate age-related macular degeneration (AMD) will progress into severe AMD. The research is being presented during a press conference at the 2017 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Baltimore, Md, on Monday, May 8 from 9:30 – 10:15 am.

• share
• favorite_border

Scientists have shown for the first time that gestational exposure to marijuana smoke in animals affects the development of the eye and these alterations seem to progress with age. The research is being presented during a press conference at the 2017 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Baltimore, Md., on Monday, May 8 from 9:30 – 10:15am.

• share
• favorite_border

Over 11,000 top eye and vision researchers and clinicians from around the world will attend the Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), May 7-11, in Baltimore, Md., to explore cutting-edge findings in basic and clinical science. The theme and focus of this year's agenda is on creating stronger global connections and effective collaborations to accelerate vision research.

• share
• favorite_border

For the first time, information about worldwide blindness and vision impairment is being projected onto NASA’s room-sized, global display system during the Annual Meeting of the Association for Research in Vision and Ophthalmology (May 7 – 11 at the Baltimore Convention Center).